Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Campylobacter Infections | 10 | 2021 | 12 | 1.890 |
Why?
|
Campylobacter jejuni | 7 | 2021 | 14 | 1.750 |
Why?
|
Mycobacterium tuberculosis | 17 | 2020 | 195 | 1.720 |
Why?
|
Selection, Genetic | 7 | 2020 | 509 | 1.590 |
Why?
|
Ribonuclease H, Human Immunodeficiency Virus | 9 | 2019 | 9 | 1.340 |
Why?
|
Models, Genetic | 7 | 2020 | 942 | 1.290 |
Why?
|
Evolution, Molecular | 9 | 2018 | 836 | 1.240 |
Why?
|
Siderophores | 7 | 2013 | 22 | 1.170 |
Why?
|
Bayes Theorem | 11 | 2021 | 368 | 1.130 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2022 | 223 | 1.060 |
Why?
|
Genome, Bacterial | 4 | 2020 | 145 | 1.030 |
Why?
|
Pyrimidinones | 7 | 2019 | 37 | 0.940 |
Why?
|
Ligases | 5 | 2012 | 45 | 0.930 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2016 | 379 | 0.910 |
Why?
|
Dyslipidemias | 4 | 2015 | 108 | 0.910 |
Why?
|
Peptide Synthases | 6 | 2016 | 12 | 0.900 |
Why?
|
HIV-1 | 8 | 2019 | 164 | 0.870 |
Why?
|
HIV Reverse Transcriptase | 6 | 2019 | 14 | 0.870 |
Why?
|
Phylogeny | 6 | 2019 | 1171 | 0.860 |
Why?
|
Bacterial Proteins | 11 | 2020 | 885 | 0.850 |
Why?
|
Antitubercular Agents | 11 | 2020 | 54 | 0.830 |
Why?
|
Enzyme Inhibitors | 9 | 2020 | 646 | 0.790 |
Why?
|
Gastroenteritis | 1 | 2021 | 26 | 0.790 |
Why?
|
Reverse Transcriptase Inhibitors | 7 | 2018 | 23 | 0.780 |
Why?
|
Structure-Activity Relationship | 23 | 2020 | 411 | 0.750 |
Why?
|
Silent Mutation | 1 | 2020 | 3 | 0.740 |
Why?
|
Transaminases | 5 | 2014 | 33 | 0.740 |
Why?
|
Genetic Techniques | 1 | 2020 | 73 | 0.710 |
Why?
|
Biotin | 4 | 2014 | 45 | 0.710 |
Why?
|
Staphylococcus aureus | 2 | 2013 | 274 | 0.670 |
Why?
|
Anti-HIV Agents | 5 | 2018 | 154 | 0.620 |
Why?
|
Heptanoic Acids | 7 | 2014 | 71 | 0.610 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 1167 | 0.610 |
Why?
|
Pyrroles | 7 | 2014 | 186 | 0.570 |
Why?
|
Recombination, Genetic | 5 | 2018 | 441 | 0.560 |
Why?
|
Adenosine | 7 | 2020 | 238 | 0.550 |
Why?
|
Genome, Microbial | 1 | 2016 | 3 | 0.550 |
Why?
|
Meat | 2 | 2021 | 27 | 0.520 |
Why?
|
Drug Design | 9 | 2019 | 124 | 0.520 |
Why?
|
Glomerular Filtration Rate | 8 | 2016 | 279 | 0.510 |
Why?
|
Uric Acid | 1 | 2015 | 136 | 0.510 |
Why?
|
Biocatalysis | 3 | 2011 | 51 | 0.500 |
Why?
|
Enzyme Assays | 2 | 2016 | 16 | 0.490 |
Why?
|
Models, Molecular | 16 | 2018 | 1295 | 0.440 |
Why?
|
Pyrazines | 1 | 2013 | 94 | 0.420 |
Why?
|
Adenine | 1 | 2012 | 88 | 0.410 |
Why?
|
Naphthyridines | 2 | 2022 | 27 | 0.410 |
Why?
|
Genes, X-Linked | 1 | 2011 | 38 | 0.400 |
Why?
|
Genetic Fitness | 1 | 2011 | 37 | 0.390 |
Why?
|
Genetics, Population | 3 | 2021 | 404 | 0.380 |
Why?
|
Animals, Wild | 2 | 2019 | 41 | 0.360 |
Why?
|
Molecular Structure | 13 | 2020 | 289 | 0.360 |
Why?
|
Spectrophotometry | 1 | 2010 | 108 | 0.360 |
Why?
|
Acyltransferases | 1 | 2010 | 41 | 0.360 |
Why?
|
IMP Dehydrogenase | 5 | 2010 | 9 | 0.360 |
Why?
|
Kinetics | 9 | 2016 | 1530 | 0.350 |
Why?
|
Microbial Sensitivity Tests | 11 | 2020 | 147 | 0.350 |
Why?
|
Antiviral Agents | 3 | 2021 | 515 | 0.350 |
Why?
|
Water Microbiology | 2 | 2009 | 13 | 0.350 |
Why?
|
Hyperkalemia | 2 | 2021 | 13 | 0.350 |
Why?
|
Hypolipidemic Agents | 1 | 2010 | 99 | 0.350 |
Why?
|
Neisseria meningitidis | 2 | 2005 | 8 | 0.330 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 268 | 0.330 |
Why?
|
Coronary Disease | 4 | 2015 | 261 | 0.330 |
Why?
|
Fluorescence Polarization | 1 | 2008 | 9 | 0.330 |
Why?
|
Chickens | 4 | 2021 | 213 | 0.320 |
Why?
|
Multilocus Sequence Typing | 3 | 2021 | 12 | 0.320 |
Why?
|
Cholesterol, LDL | 5 | 2015 | 223 | 0.320 |
Why?
|
Campylobacter | 3 | 2015 | 5 | 0.310 |
Why?
|
Drosophila | 1 | 2011 | 511 | 0.300 |
Why?
|
Drug Discovery | 3 | 2019 | 107 | 0.290 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 605 | 0.290 |
Why?
|
Uracil | 2 | 2017 | 56 | 0.280 |
Why?
|
Potassium | 3 | 2022 | 253 | 0.270 |
Why?
|
Porins | 1 | 2005 | 21 | 0.270 |
Why?
|
Coenzyme A Ligases | 2 | 2020 | 7 | 0.270 |
Why?
|
Humans | 46 | 2022 | 88611 | 0.260 |
Why?
|
Sirtuin 2 | 2 | 2016 | 9 | 0.260 |
Why?
|
Computer Simulation | 7 | 2018 | 1095 | 0.250 |
Why?
|
Substrate Specificity | 5 | 2016 | 352 | 0.250 |
Why?
|
Crystallography, X-Ray | 8 | 2017 | 487 | 0.250 |
Why?
|
Tuberculosis | 3 | 2013 | 121 | 0.250 |
Why?
|
Mycophenolic Acid | 3 | 2010 | 88 | 0.240 |
Why?
|
DNA, Bacterial | 4 | 2018 | 238 | 0.220 |
Why?
|
Mutation | 7 | 2012 | 4097 | 0.220 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 361 | 0.210 |
Why?
|
Anticholesteremic Agents | 3 | 2008 | 137 | 0.210 |
Why?
|
Mineralocorticoid Receptor Antagonists | 1 | 2022 | 17 | 0.210 |
Why?
|
Spironolactone | 1 | 2022 | 12 | 0.210 |
Why?
|
Double-Blind Method | 7 | 2016 | 1716 | 0.210 |
Why?
|
Animals | 18 | 2021 | 27233 | 0.200 |
Why?
|
Escherichia coli Proteins | 4 | 2013 | 183 | 0.200 |
Why?
|
Campylobacter coli | 3 | 2010 | 3 | 0.200 |
Why?
|
Genetic Variation | 6 | 2018 | 1369 | 0.200 |
Why?
|
Catalytic Domain | 6 | 2019 | 157 | 0.200 |
Why?
|
Zika Virus | 1 | 2021 | 14 | 0.200 |
Why?
|
Zika Virus Infection | 1 | 2021 | 13 | 0.200 |
Why?
|
Whole Genome Sequencing | 1 | 2021 | 85 | 0.190 |
Why?
|
Protein Structure, Tertiary | 5 | 2016 | 741 | 0.190 |
Why?
|
England | 3 | 2010 | 39 | 0.190 |
Why?
|
HIV Infections | 6 | 2018 | 829 | 0.180 |
Why?
|
Markov Chains | 2 | 2018 | 127 | 0.180 |
Why?
|
Tuberculosis, Bovine | 1 | 2019 | 1 | 0.180 |
Why?
|
Sulfonamides | 4 | 2020 | 318 | 0.180 |
Why?
|
HIV Integrase Inhibitors | 2 | 2017 | 3 | 0.180 |
Why?
|
DEAD-box RNA Helicases | 1 | 2020 | 64 | 0.180 |
Why?
|
Kidney Failure, Chronic | 3 | 2009 | 414 | 0.180 |
Why?
|
Mycobacterium bovis | 1 | 2019 | 16 | 0.180 |
Why?
|
Virus Replication | 1 | 2021 | 322 | 0.170 |
Why?
|
Monte Carlo Method | 2 | 2018 | 186 | 0.170 |
Why?
|
Time Factors | 5 | 2018 | 5319 | 0.170 |
Why?
|
Cattle | 4 | 2019 | 375 | 0.170 |
Why?
|
Aged | 15 | 2021 | 18932 | 0.170 |
Why?
|
Host-Pathogen Interactions | 2 | 2019 | 235 | 0.170 |
Why?
|
Machine Learning | 1 | 2021 | 242 | 0.170 |
Why?
|
Valosin Containing Protein | 1 | 2019 | 4 | 0.170 |
Why?
|
Adenine Nucleotides | 2 | 2010 | 63 | 0.170 |
Why?
|
Shigella sonnei | 1 | 2018 | 1 | 0.170 |
Why?
|
Mycobacterium leprae | 1 | 2018 | 6 | 0.170 |
Why?
|
Triazoles | 2 | 2010 | 100 | 0.160 |
Why?
|
Niacinamide | 2 | 2016 | 115 | 0.160 |
Why?
|
Streptococcus pneumoniae | 1 | 2018 | 49 | 0.160 |
Why?
|
Kidney | 3 | 2015 | 1145 | 0.160 |
Why?
|
Datasets as Topic | 1 | 2018 | 76 | 0.160 |
Why?
|
Pyrimidines | 1 | 2021 | 372 | 0.160 |
Why?
|
Benchmarking | 1 | 2018 | 79 | 0.160 |
Why?
|
Sequence Analysis, DNA | 5 | 2013 | 863 | 0.150 |
Why?
|
Bacterial Typing Techniques | 4 | 2011 | 28 | 0.150 |
Why?
|
Hypertension | 2 | 2017 | 733 | 0.150 |
Why?
|
Genetic Drift | 2 | 2008 | 37 | 0.150 |
Why?
|
Thiophenes | 1 | 2017 | 43 | 0.150 |
Why?
|
Software | 2 | 2018 | 663 | 0.150 |
Why?
|
HIV | 1 | 2017 | 48 | 0.150 |
Why?
|
Communicable Diseases | 1 | 2018 | 63 | 0.150 |
Why?
|
Disease Outbreaks | 1 | 2018 | 155 | 0.150 |
Why?
|
Disease Reservoirs | 3 | 2019 | 22 | 0.150 |
Why?
|
High-Throughput Screening Assays | 3 | 2014 | 58 | 0.150 |
Why?
|
Diuretics | 1 | 2017 | 75 | 0.140 |
Why?
|
Chelating Agents | 1 | 2017 | 69 | 0.140 |
Why?
|
Stereoisomerism | 3 | 2011 | 102 | 0.140 |
Why?
|
Molecular Epidemiology | 3 | 2011 | 53 | 0.140 |
Why?
|
Ribonuclease H | 1 | 2016 | 8 | 0.140 |
Why?
|
Lipids | 2 | 2008 | 272 | 0.140 |
Why?
|
Polymorphism, Genetic | 3 | 2011 | 825 | 0.140 |
Why?
|
Molecular Docking Simulation | 4 | 2019 | 46 | 0.140 |
Why?
|
Cyclobutanes | 1 | 2016 | 7 | 0.140 |
Why?
|
Computational Biology | 2 | 2018 | 542 | 0.140 |
Why?
|
Cluster Analysis | 3 | 2012 | 371 | 0.140 |
Why?
|
Hydroxylamine | 1 | 2016 | 5 | 0.140 |
Why?
|
Pravastatin | 1 | 2015 | 17 | 0.130 |
Why?
|
Polymers | 1 | 2017 | 194 | 0.130 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 69 | 0.130 |
Why?
|
Male | 18 | 2021 | 42012 | 0.130 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 16 | 0.130 |
Why?
|
Cloning, Molecular | 2 | 2013 | 647 | 0.120 |
Why?
|
Female | 18 | 2021 | 45759 | 0.120 |
Why?
|
Coenzyme A | 1 | 2014 | 15 | 0.120 |
Why?
|
Genomics | 1 | 2019 | 747 | 0.120 |
Why?
|
Amide Synthases | 1 | 2013 | 1 | 0.120 |
Why?
|
Hydrazines | 1 | 2014 | 31 | 0.120 |
Why?
|
Pyridines | 1 | 2016 | 316 | 0.120 |
Why?
|
Drug Tolerance | 1 | 2013 | 62 | 0.110 |
Why?
|
Hydroxamic Acids | 2 | 2010 | 51 | 0.110 |
Why?
|
Stroke | 2 | 2014 | 980 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2017 | 1945 | 0.110 |
Why?
|
Acinetobacter baumannii | 1 | 2013 | 26 | 0.110 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 182 | 0.110 |
Why?
|
Cell Line | 4 | 2018 | 2498 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 217 | 0.100 |
Why?
|
Methicillin | 1 | 2012 | 4 | 0.100 |
Why?
|
Cross Infection | 1 | 2013 | 146 | 0.100 |
Why?
|
Ligands | 2 | 2014 | 440 | 0.100 |
Why?
|
Swine | 2 | 2015 | 582 | 0.100 |
Why?
|
Bacteria | 1 | 2016 | 468 | 0.100 |
Why?
|
Heart Failure | 2 | 2012 | 1171 | 0.100 |
Why?
|
Codon | 1 | 2011 | 122 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2011 | 119 | 0.100 |
Why?
|
Streptavidin | 1 | 2011 | 14 | 0.100 |
Why?
|
Clostridium Infections | 1 | 2013 | 125 | 0.100 |
Why?
|
Binding Sites | 4 | 2017 | 1113 | 0.100 |
Why?
|
Genome, Insect | 1 | 2011 | 76 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2011 | 85 | 0.100 |
Why?
|
Molecular Conformation | 1 | 2011 | 96 | 0.100 |
Why?
|
Fluorescence | 1 | 2011 | 103 | 0.100 |
Why?
|
Lyases | 1 | 2010 | 11 | 0.100 |
Why?
|
Gene Deletion | 1 | 2012 | 342 | 0.090 |
Why?
|
Escherichia coli | 2 | 2012 | 605 | 0.090 |
Why?
|
Nucleosides | 2 | 2008 | 22 | 0.090 |
Why?
|
Enterobactin | 1 | 2010 | 1 | 0.090 |
Why?
|
Disease Transmission, Infectious | 2 | 2013 | 58 | 0.090 |
Why?
|
Diphosphates | 1 | 2010 | 18 | 0.090 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2010 | 23 | 0.090 |
Why?
|
Pyrophosphatases | 1 | 2010 | 16 | 0.090 |
Why?
|
Acylation | 1 | 2010 | 40 | 0.090 |
Why?
|
Enteritis | 1 | 2010 | 21 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2010 | 92 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 2538 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 243 | 0.090 |
Why?
|
Chromosome Segregation | 1 | 2009 | 32 | 0.090 |
Why?
|
Gene Frequency | 1 | 2011 | 684 | 0.090 |
Why?
|
Health Surveys | 1 | 2010 | 239 | 0.090 |
Why?
|
Vero Cells | 3 | 2020 | 101 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2015 | 6723 | 0.090 |
Why?
|
Health Maintenance Organizations | 1 | 2009 | 20 | 0.080 |
Why?
|
Middle Aged | 12 | 2021 | 25699 | 0.080 |
Why?
|
Amlodipine | 1 | 2008 | 5 | 0.080 |
Why?
|
Compliance | 1 | 2008 | 21 | 0.080 |
Why?
|
Hydroxybenzoates | 1 | 2008 | 6 | 0.080 |
Why?
|
Salicylic Acid | 1 | 2008 | 39 | 0.080 |
Why?
|
Genotype | 5 | 2011 | 1867 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 858 | 0.080 |
Why?
|
Sheep | 1 | 2008 | 250 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2013 | 679 | 0.080 |
Why?
|
Oxazoles | 1 | 2007 | 19 | 0.080 |
Why?
|
Arteries | 1 | 2008 | 181 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 777 | 0.070 |
Why?
|
Rabbits | 1 | 2008 | 640 | 0.070 |
Why?
|
Disease Progression | 1 | 2012 | 1490 | 0.070 |
Why?
|
Genetic Speciation | 1 | 2008 | 115 | 0.070 |
Why?
|
Chemistry Techniques, Synthetic | 2 | 2017 | 9 | 0.070 |
Why?
|
Gene Products, env | 1 | 2006 | 5 | 0.070 |
Why?
|
Sulfhydryl Compounds | 1 | 2007 | 71 | 0.070 |
Why?
|
Birds | 1 | 2008 | 161 | 0.070 |
Why?
|
Comorbidity | 1 | 2010 | 947 | 0.070 |
Why?
|
Poultry | 3 | 2011 | 23 | 0.070 |
Why?
|
New Zealand | 3 | 2011 | 22 | 0.070 |
Why?
|
Biodiversity | 1 | 2008 | 202 | 0.070 |
Why?
|
Prevalence | 1 | 2010 | 1248 | 0.070 |
Why?
|
Hospitalization | 1 | 2012 | 871 | 0.070 |
Why?
|
Models, Statistical | 2 | 2009 | 575 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2017 | 105 | 0.070 |
Why?
|
Madin Darby Canine Kidney Cells | 2 | 2016 | 19 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2012 | 2399 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2016 | 3655 | 0.060 |
Why?
|
United States | 3 | 2016 | 6882 | 0.060 |
Why?
|
Dogs | 2 | 2016 | 704 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 927 | 0.060 |
Why?
|
Poultry Diseases | 2 | 2015 | 13 | 0.060 |
Why?
|
Genes, Bacterial | 1 | 2004 | 198 | 0.060 |
Why?
|
Pyridones | 2 | 2016 | 53 | 0.060 |
Why?
|
Risk Assessment | 1 | 2011 | 2286 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 1592 | 0.060 |
Why?
|
Haplotypes | 1 | 2005 | 637 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 743 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2019 | 1647 | 0.050 |
Why?
|
Adult | 9 | 2016 | 26348 | 0.050 |
Why?
|
Risk Factors | 3 | 2021 | 5449 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 707 | 0.050 |
Why?
|
Sulfonic Acids | 2 | 2014 | 9 | 0.050 |
Why?
|
DNA Fingerprinting | 2 | 2010 | 16 | 0.050 |
Why?
|
Mustelidae | 1 | 2019 | 4 | 0.040 |
Why?
|
Rural Population | 2 | 2011 | 143 | 0.040 |
Why?
|
Food Microbiology | 2 | 2009 | 9 | 0.040 |
Why?
|
Urban Population | 2 | 2011 | 223 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2019 | 64 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 2406 | 0.040 |
Why?
|
Sierra Leone | 1 | 2018 | 3 | 0.040 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2018 | 11 | 0.040 |
Why?
|
Methylation | 1 | 2018 | 267 | 0.040 |
Why?
|
Hypokalemia | 1 | 2017 | 23 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2017 | 38 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 90 | 0.040 |
Why?
|
Raltegravir Potassium | 1 | 2016 | 2 | 0.040 |
Why?
|
HIV Integrase | 1 | 2016 | 5 | 0.040 |
Why?
|
Oxazines | 1 | 2016 | 13 | 0.040 |
Why?
|
Risk | 2 | 2008 | 660 | 0.030 |
Why?
|
Constipation | 1 | 2017 | 63 | 0.030 |
Why?
|
Crystallization | 1 | 2017 | 210 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2016 | 30 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2016 | 51 | 0.030 |
Why?
|
Drug Stability | 1 | 2016 | 48 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 2016 | 49 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2016 | 17 | 0.030 |
Why?
|
Sirtuins | 1 | 2016 | 46 | 0.030 |
Why?
|
Cattle Diseases | 1 | 2015 | 6 | 0.030 |
Why?
|
Swine Diseases | 1 | 2015 | 14 | 0.030 |
Why?
|
Chronic Disease | 2 | 2011 | 948 | 0.030 |
Why?
|
Guanosine | 1 | 2016 | 30 | 0.030 |
Why?
|
Host Specificity | 1 | 2015 | 11 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 114 | 0.030 |
Why?
|
Mice | 3 | 2016 | 11710 | 0.030 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2016 | 103 | 0.030 |
Why?
|
Calorimetry | 1 | 2014 | 15 | 0.030 |
Why?
|
Creatinine | 1 | 2016 | 295 | 0.030 |
Why?
|
Neoplasms | 1 | 2010 | 3009 | 0.030 |
Why?
|
Suramin | 1 | 2014 | 27 | 0.030 |
Why?
|
Cause of Death | 1 | 2016 | 270 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 2014 | 144 | 0.030 |
Why?
|
Piperazines | 1 | 2016 | 280 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2014 | 114 | 0.030 |
Why?
|
Prospective Studies | 2 | 2016 | 4271 | 0.030 |
Why?
|
Luciferases | 1 | 2013 | 128 | 0.030 |
Why?
|
United Kingdom | 1 | 2013 | 162 | 0.030 |
Why?
|
Child | 3 | 2010 | 7089 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2013 | 115 | 0.030 |
Why?
|
Amino Acids | 1 | 2014 | 252 | 0.030 |
Why?
|
Child, Preschool | 2 | 2010 | 3678 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 249 | 0.030 |
Why?
|
Hydrolases | 1 | 2012 | 30 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2010 | 2445 | 0.030 |
Why?
|
Models, Biological | 2 | 2011 | 1764 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2011 | 23 | 0.020 |
Why?
|
Survival Rate | 1 | 2016 | 1883 | 0.020 |
Why?
|
Adolescent | 3 | 2010 | 9157 | 0.020 |
Why?
|
Scotland | 1 | 2010 | 5 | 0.020 |
Why?
|
Sulfones | 1 | 2010 | 45 | 0.020 |
Why?
|
Agriculture | 1 | 2010 | 39 | 0.020 |
Why?
|
Calibration | 1 | 2010 | 102 | 0.020 |
Why?
|
Cinnamates | 1 | 2010 | 8 | 0.020 |
Why?
|
Pantothenic Acid | 1 | 2010 | 1 | 0.020 |
Why?
|
Ruminants | 1 | 2010 | 6 | 0.020 |
Why?
|
Foodborne Diseases | 1 | 2010 | 8 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 65 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 884 | 0.020 |
Why?
|
Thiazoles | 1 | 2010 | 128 | 0.020 |
Why?
|
Dimerization | 1 | 2010 | 143 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 179 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 565 | 0.020 |
Why?
|
Poultry Products | 1 | 2009 | 2 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2010 | 70 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2010 | 113 | 0.020 |
Why?
|
Catalysis | 1 | 2010 | 205 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2009 | 54 | 0.020 |
Why?
|
Crossing Over, Genetic | 1 | 2009 | 33 | 0.020 |
Why?
|
Manure | 1 | 2009 | 3 | 0.020 |
Why?
|
Zoonoses | 1 | 2009 | 26 | 0.020 |
Why?
|
Animals, Domestic | 1 | 2009 | 11 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 78 | 0.020 |
Why?
|
Seasons | 1 | 2010 | 233 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2008 | 7 | 0.020 |
Why?
|
Placebos | 1 | 2008 | 214 | 0.020 |
Why?
|
Population Surveillance | 1 | 2009 | 217 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2010 | 1020 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 179 | 0.020 |
Why?
|
Young Adult | 2 | 2010 | 6218 | 0.020 |
Why?
|
Triglycerides | 1 | 2008 | 232 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2008 | 314 | 0.020 |
Why?
|
Feces | 1 | 2009 | 326 | 0.020 |
Why?
|
Alleles | 1 | 2010 | 1132 | 0.020 |
Why?
|
NAD | 1 | 2007 | 68 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 75 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2007 | 166 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 799 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 612 | 0.020 |
Why?
|
Genes, Viral | 1 | 2006 | 117 | 0.020 |
Why?
|
HIV Core Protein p24 | 1 | 2006 | 7 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2006 | 19 | 0.020 |
Why?
|
Homosexuality | 1 | 2006 | 9 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2006 | 77 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2008 | 902 | 0.020 |
Why?
|
Cell Wall | 1 | 2006 | 66 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2006 | 46 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2009 | 8178 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 315 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 1662 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2007 | 319 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2011 | 2346 | 0.010 |
Why?
|
Blood Pressure | 1 | 2007 | 893 | 0.010 |
Why?
|
Infant | 1 | 2010 | 3117 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 1214 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 2331 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 3029 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 8893 | 0.010 |
Why?
|